USD 1.08 billion
3D Bioprinting Market Size, Share, Growth Analysis, By Component(3D Bioprinters and Bioinks), By Material(Living Cell and Hydrogel), By Technology(Inkjet-based and Magnetic Levitation), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG20I2072 |
Region:
Global |
Published Date: August, 2024
Pages:
157
|Tables:
150
|Figures:
81
3D Bioprinting Market Insights
Global 3D Bioprinting Market size was valued at USD 1.08 Billion in 2022 and is poised to grow from USD 1.3 Billion in 2023 to USD 5.92 Billion by 2031, growing at a CAGR of 20.8% in the forecast period (2024-2031).
Primary drivers of this market expansion include the aging population with chronic respiratory disorders and the scarcity of organ donors. Rising R&D spending, technological advancement, and the rise in the prevalence of chronic illnesses are all expected to drive market expansion over the course of the forecast period. The ability of technology to create complex solid organs such as hearts, kidneys, and lungs for transplantation is driving the growing importance of 3D printing in the medical sector. Moreover, 3D bioprinting technology makes it easier to create customized organ and tissue architectures according to a patient's requirements, allowing for more specialized medical procedures and transplants. They solve the organ shortage and provide better approaches in cases of complicated diseases. For this and many other reasons, with the increasing demand in healthcare for personalized patient treatment, it's a driving force for high-performance bioprinters.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Inkjet-based
Fastest Growth
Inkjet-based
Growth Rate
20.8% CAGR
Global 3D Bioprinting Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
3D Bioprinting Market Segmental Analysis
The Global 3D Bioprinting Market is segmented into component, material, technology, and region. By component, the market is classified into 3D Bioprinters and Bioinks. Depending on material, it is categorized into living cell and hydrogel. According to technology, the market is bifurcated into inkjet-based and magnetic levitation. Regionally, it is analyzed across North America, Latin America, Europe, Middle East & Africa, and Asia-Pacific.
Analysis By Technology
With the aid of biomaterials, bio-inks, this technology allows for the printing of intricate living organs or tissues on culture substrates, which is why the inkjet-based segment held the greatest share in 2022. The expansion of this market is being aided by the widespread use of inkjet-based printing in the medical industry. The study trends in inkjet printing as a bio applicable technology are presented in this paper, particularly in the areas of drug delivery systems and tissue engineering. This category is expected to increase significantly during the projection period because of its higher reliability and growing demand.
During the forecast period, the magnetic levitation segment is expected to grow at the fastest rate. The technology's cost-effectiveness is responsible for the profitable growth. It is anticipated that magnetic levitation technology, with its advanced features, increased speed, and precision, will resolve over 80.0% of the mistakes in 3D bioprinting.
Analysis By Material
The living cells segment is the largest segment by material in the global 3D bioprinting market. Applications can readily be identified in drug discovery, regenerative medicine, personalized medicine, and many other areas that involve living cells for developing complex tissue structures. Living cells represent functional biological units that are considered suitable for the construction of tissues and organs. Recent developments in stem cell research and tissue engineering spur a rise in demand for living cells to facilitate customized, patient-specific tissue creation with unprecedented rapidity.
The hydrogels segment is the fastest growing in the global 3D Bioprinting market. Their high-water content, their biocompatibility, and ability to mimic the extracellular matrix in place and through which segmental growth occurs make them unique. Hydrogels act as bio-inks that allow the encapsulation of cells and the creation of an environment which allows for tissue growth to take place. Growing interest in tissue engineering and applications related to regenerative medicine is driving market growth.
Global 3D Bioprinting Market By Material
To get detailed analysis on other segments, Request For Free Sample Report
3D Bioprinting Market Regional Insights
North America holds a leading position in the 3D bioprinting market over the forecast period. It is anticipated that the healthcare industry's increasing reliance on IT will lead to growth. Furthermore, developed countries such as the US and Canada are allocating more funds for advanced manufacturing technology. Furthermore, several governmental agencies, such as the National Aeronautics and Space Administration (NASA), have realized the importance of allocating substantial resources to research and development (R&D) to significantly progress space applications and produce innovative technologies that promote economic growth.
The second-largest proportion of the global market is held by Europe. Small and medium-sized businesses are vying for this technology as they need fast, trustworthy, and reasonably priced prototypes for mass production. It is projected that the semiconductor and manufacturing industries in the region will use this technology much more frequently. Many laws and regulations have been implemented by regional governments in response to businesses' growing interest in developing a sustainable 3D printing environment.
Global 3D Bioprinting Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
3D Bioprinting Market Dynamics
Drivers
Expanding Applications of 3D Bioprinting in the Pharmaceutical and Cosmetic Industries
- Many pharmaceutical companies are finding and developing novel pharmaceuticals rapidly by utilizing 3D bioprinting products and technology. 3D printing of tissues is more secure and reasonably priced in drug testing in the pharmaceutical business compared to the traditional approach. Due to this 3D bioprinting technology, testing of a medicine may be done by pharmaceutical companies within a few hours instead of the three to six years it takes to manufacture a new one. With the support of 3D bioprinted tissues, R&D teams may perform early and preclinical testing of candidate drugs. Other major advantages of three-dimensional bioprinting include reduction of animal testing, more production, and faster development of drugs.
Increasing Demand for Personalized and Regenerative Medicines
- 3D bioprinting technology allows patients to have their own tissue and organ structures printed for themselves during personalized medical treatment and organ transplantation. They also help to address the organ shortage issue and increase the effectiveness of treatments for complex medical conditions. And so, the increasing emphasis in the healthcare industry on tailored patient care is driving the need for advanced bioprinting technologies. This is stimulating investment and innovation in the sector, which will support its expansion.
Restraints
Costly and Complicated Bioprinting Technology
- It is very difficult for different research groups and medical facilities to adopt and implement these technologies. This is due to the exorbitant expense of the machinery and bioinks necessary to develop functional tissues and organs. In addition, these treatments require complex protocols and the expertise of experienced faculty members, which increases operating expenses and limits the procedures' potential for broad adoption.
Lack of Biomaterials is Putting Industry in Danger
- One of the main issues facing the 3D bioprinting market is the lack of readily available biomaterials for the procedure. Both the extraction of manufactured items and the operating procedures involved in waste disposal are part of the process of producing biomaterials. These control system variables slow down industrial operations and increase the chance of procedure variation, which leads to major issues for a range of machines and processes.
Request Free Customization of this report to help us to meet your business objectives.
3D Bioprinting Market Competitive Landscape
The market is highly heterogeneous in nature and has constantly undergone rapid changes. This is a very highly technology-driven and competitive market that decides the company behavior. Large companies have been encouraging the growth of the bioprinting market by their strategic collaborations, product portfolio expansion, and development of improved bioprinting technologies. Some of the large companies in the market are 3D Systems Corporation, Organovo Holdings Inc., BICO Group AB, and Merck KGaA. Certain key contemporary tendencies influencing the sector include high-resolution bioprinting techniques, entry into the market by emerging economies, and attempts to navigate complex regulatory regimes.
Top Player’s Company Profiles
- Merck KGaA
- Poietis SAS
- Allevi, Inc.
- BICO Group AB
- Tissuelabs
- Materialise NV
- 3D Biotek, LLC
- Microdrop Technologies GmbH
- REGEMAT 3D, SL
- MEDPRIN
- PRODWAYS
- Stratasys Ltd.
- Organovo Holdings, Inc.
- CELLINK AB
- Tissuelabs
Recent Developments
- April 2023: Stratasys and CollPlant Biotechnologies Ltd. announced a joint development and commercialization partnership for human tissue and organs biofabrication. With the partnership, Programmable Photopolymerization technology was brought by Stratasys to the partnership with CollPlant Biotechnologies Ltd.'s rhCollagen-based bioinks. Both companies were now able to make a greater contribution to development in advanced, bio-printed human tissues and organs in the regenerative medicine field.
- May 2022: All shares of San Diego-based Allegro 3D Inc. were acquired by BICO Group AB for an upfront enterprise value of USD 6 million. This acquisition cemented BICO Group AB's leadership in 3D bioprinting solutions globally by broadening its range of advanced bioprinting technologies.
- November 2021: CollPlant Biotechnologies Ltd., a leader in regenerative and cosmetic medicine, announced the introduction of Collink.3D, a recombinant human collagen (rhCollagen)-based bioInk solution for 3D bioprinting. Therefore, colllink.3D is the initial commercially available rhCollagen-based bioInk product that CollPlant Biotechnologies Ltd. is putting forward to make biofabrication for the scaffold, tissue, and organ transplantation scalable and repeatable. With this launch, CollPlant Biotechnologies Ltd. leads 3D bioprinting innovations while securing solid opportunities within the tissue regeneration and organ production markets. As a result, the company is expected to witness growth.
3D Bioprinting Key Market Trends
- More alliances formed among research organizations, biotechnology companies, and university institutions fasten the pace of development for 3D bioprinting technologies. This leads to exchanges in knowledge and resources, producing breakthroughs that drive growth in the market.
- Now, with the current trend of personalized therapy in the medical field, there is more need for generating patient-specific models and implants. Further, the continuing trend toward more personalized care will provide a drive for technology that can make tissues and organs according to patient needs.
3D Bioprinting Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest Analysis, 3D bioprinting consists of the production of a three-dimensional object with a similar anatomical texture to biological tissues and organs by millions of cells associated with several growth hormones, layer by layer. Technology allows a digital model to guide the behavior of exact cellular, biomaterial, and growth hormone makeups in the creation of a tissue structure. This is the most current method of 3D bioprinting for use by elaboration efforts, drug studies, and regenerative medicine. Thus, 3D bioprinting is an application whose fuel is drawn from the changing needs of personalized medicine and the increase in chronic diseases. With a greater focus on treatment that is custom-tailored to the patient and tissue substitute professionally engineered, 3D bioprinting offers an efficient way for the fabrication of patient-specific implants and tissue models.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.08 Billion |
| Market size value in 2031 | USD 5.92 Billion |
| Growth Rate | 20.8% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on 3D Bioprinting Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on 3D Bioprinting Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the 3D Bioprinting Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the 3D Bioprinting Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the 3D Bioprinting Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the 3D Bioprinting Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
